(+/-)-BLEBBISTATIN
(+/-)-BLEBBISTATIN 性质
| 熔点 | 210-212°C |
|---|---|
| 沸点 | 507.3±60.0 °C(Predicted) |
| 密度 | 1.31±0.1 g/cm3(Predicted) |
| 储存条件 | −20°C |
| 溶解度 | 可溶于氯仿（少量）、二氯甲烷、DMSO、乙酸乙酯、甲醇 |
| 形态 | 亮黄色固体。 |
| 酸度系数(pKa) | 11.15±0.20(Predicted) |
| 颜色 | 粘黄色 |
| CAS 数据库 | 674289-55-5 |
(+/-)-BLEBBISTATIN 用途与合成方法
Non-muscle myosin II (NMII)
The therapeutic potential of targeting NMII to enhance CEC migration is investigated using bovine corneal endothelial cells (BCECs). Blebbistatin, a direct myosin motor inhibitor, promotes migration and directional persistence in CECs through decreasing actin retrograde flow and increasing lamellipodial protrusion persistence to accelerate wound healing in vitro.
Blebbistatin (0.05 mL, 20 μM; intracameral injection; daily; for 6 days; New Zealand white rabbits) treatment promotes wound healing in rabbit corneal endothelial scraping model.
| Animal Model: | New Zealand white rabbits (16-20 weeks; 3-3.5 kg) |
| Dosage: | 0.05 mL; 20 μM |
| Administration: | Intracameral injection; daily; for 6 days |
| Result: | Resulted in significant improvement of corneal clarity and corneal edema resolution, implying the restoration of an intact corneal endothelial monolayer. |
Blebbistatin blocked myosin II-dependent cell processes. It blocks cell blebbing rapidly and reversibly. Also rapidly disrupted directed cell migration and cytokinesis in vertebrate cell. It blocks both blebbing and cytokinesis at 50-100μM.
